W. Michael Flanagan is CSTO of Avidity Biosciences, Inc.. Currently has a direct ownership of 72,647 shares of RNA, which is worth approximately $2.19 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 12,742 shares (Common Stock) at a price of $32.66 per share, resulting in proceeds of $416,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.6K
14.92% 3M change
80.31% 12M change
Total Value Held $2.19 Million

W. Michael Flanagan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
SELL
Open market or private sale
$416,153 $32.66 p/Share
12,742 Reduced 14.92%
72,647 Common Stock
Dec 11 2024
SELL
Open market or private sale
$858,480 $35.77 p/Share
24,000 Reduced 21.94%
85,389 Common Stock
Dec 11 2024
BUY
Exercise of conversion of derivative security
$539,280 $22.47 p/Share
24,000 Added 17.99%
109,389 Common Stock
Oct 01 2024
SELL
Open market or private sale
$2,976,250 $47.62 p/Share
62,500 Reduced 42.26%
85,389 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
$1,671,875 $26.75 p/Share
62,500 Added 29.71%
147,889 Common Stock
Sep 23 2024
SELL
Open market or private sale
$1,098,750 $43.95 p/Share
25,000 Reduced 22.65%
85,389 Common Stock
Sep 19 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 33.85%
97,718 Common Stock
Sep 11 2024
SELL
Open market or private sale
$4,500,317 $40.4 p/Share
111,394 Reduced 64.66%
60,871 Common Stock
Sep 11 2024
BUY
Exercise of conversion of derivative security
$2,374,865 $24.61 p/Share
96,500 Added 46.78%
109,765 Common Stock
Jun 18 2024
SELL
Open market or private sale
$395,447 $39.13 p/Share
10,106 Reduced 16.6%
50,765 Common Stock
Jun 17 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 39.76%
75,765 Common Stock
Jan 22 2024
SELL
Open market or private sale
$41,826 $10.13 p/Share
4,129 Reduced 10.32%
35,871 Common Stock
Jan 20 2024
BUY
Grant, award, or other acquisition
-
20,000 Added 49.64%
20,290 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 49.82%
40,290 Common Stock
WMF

W. Michael Flanagan

CSTO
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA